¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Men's Rogaine Extra Strength Topical Solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extra-abdominal
    º¹ºÎ¿Ü-
  • extra-axial
    ½Å°æÃà¿Ü-
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕ°­µµ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • physical strength
    ü·Â
  • strength
    1. ¼¼±â, °­µµ 2. Èû
  • strength duration curve
    °­µµ±â°£°î¼±
  • shearing strength
    Àü´Ü°­µµ, ¾ù°¥¸²¼¼±â
  • tearing strength
    Âõ±è°­µµ, Àο­°­µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • topical anesthesia
    ±¹¼Ò¸¶Ãë, Á¡¾È¸¶Ãë
  • topical antibiotic
    ±¹¼ÒÇ×»ýÁ¦
  • topical therapy
    ±¹¼Ò¿ä¹ý
  • strength
    Èû, ¼¼±â
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • physical strength
    ü·Â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
  • solution
    ¿ë¾×
  • balanced salt solution
    ÆòÇü¿°¾×
  • buffer solution
    ¿ÏÃæ¾×
  • hypotonic solution
    ÀúÀå¾×, ³·Àº»ïÅõ¾Ð¿ë¾×
  • Lugol's solution
    ·ç°ñ¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • Ringer's lactate solution
    ¸µ°ÅÁ¥»ê¿ë¾×
  • saturated solution
    Æ÷È­¿ë¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extra-axial
    ½Å°æÃà¿Ü-
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • topical anesthesia
    ±¹¼Ò¸¶Ãë, Á¡¾È¸¶Ãë
  • topical antibiotic
    ±¹¼ÒÇ×»ýÁ¦
  • topical drug
    ±¹¼Ò¾à
  • topical therapy
    ±¹¼Ò¿ä¹ý
  • back strength
    µîÈû
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕÈû
  • strength duration curve
    °­µµ±â°£°î¼±
  • dynamic strength
    µ¿Àû±Ù·Â
  • ego strength
    ÀÚ¾ÆÈû
  • field strength
    ÀÚÀå¼¼±â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â, °¡ÀåÀÚ¸®ÀÚÀå¼¼±â
  • grasp strength
    Áã´ÂÈû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accessory bone =extra ossicle
    Á¾ÀÚ°ñ(ðúí­Íé), ºÎ°ñ(ÜùÍé), À׿©°ñ(í¥æ®Íé).
  • fracture strength
    ÆÄÀý °­µµ.
  • fracture strength
    ÆÄÀý°­µµ.
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • Alsevers solution
    ¾Ù¼­¹ö¿ë¾× (¸é¾çÇ÷¾×º¸Á¸¾×)
  • Calots solution
    Ä®·Î¾×.
  • Chameleon solution
    Ä«¸á·¹¿Â¿ë¾×.
  • Channings solution
    Âù´×¾×.
  • Chenzinsky-Plein solution
    þÁø½ºÅ²-Ç÷¹Àο°»ö¾×.
  • Earies solution
    Earle¿ë¾×
  • Fowlers solution
    ÆÄ¿ï·¯ ¾×
  • Hanks solution
    ÇÚÅ©¿ë¾×
  • Hanks solution
    ÇàÅ© ÆòÇü¿°¿ë¾×
  • Hartmann s hypotonic solution
    Çϸ£Æ®¸¸ÀúÀå¾×.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accessory bone =extra ossicle
    Á¾ÀÚ°ñ(ðúí­Íé), ºÎ°ñ(ÜùÍé), À׿©°ñ(í¥æ®Íé).
  • low-ionic--strength salt solution =LISS
    ÀúÀ̿°­µµ¿°¿ë¾×
  • low-ionic-strength salt solution TEST = LISS test
    ÀúÀ̿°­µµ¿°¿ë¾×
  • mens =mind ³ª
    Á¤½Å(ïñãê).
  • mens rea
    ¹üÁËÀǵµ.
  • surface anesthesia ³ª topical a.
    Ç¥¸é¸¶Ãë(¹ý)(øúØüØ«ö­Ûö).
  • topical anesthesia
    ±¹¼Ò¸¶Ãë(¡­Ø«ö­).
  • topical anesthesia
    ±¹¼Ò¸¶Ãë, Á¡¾È¸¶Ãë
  • topical antibiotic
    ±¹¼Ò Ç×»ýÁ¦
  • topical antipruritic
    ±¹¼Ò °¡·Á¿ò¿ÏÈ­Á¦
  • topical drug
    ±¹¼Ò¾àÁ¦
  • topical therapy
    ±¹¼ÒÄ¡·á
  • back strength
    ¹è±Ù·Â.
  • bending strength
    ±¼°î °­µµ(ÏÝÍØË­Óø).
  • bonding strength
    °áÇÕ·Â(Ì¿ùêæ³).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Schaudinn's solution
    »þ¿ìµò°íÁ¤¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extra arm
    ? ÆÈ
  • bond strength
    °áÇÕ·Â(Ì¿ùêÕô)
  • dipole strength
    ½Ö±ØÀÚ(äªÐ¿í­) ¼¼±â
  • eluent strength
    ¿ë¸®(éÁ×î) ¼¼±â
  • ionic strength
    À̿ °­µµ(Ë­Óø)
  • promoter strength
    ÇÁ·Î¸ðÅÍ °­µµ(Ë­Óø)
  • rotational strength
    ȸÀü(üÞï®) ¼¼±â
  • ACD-solution
    ACD ¿ë¾×(éÁäû)
  • acid-citrate-dextrose solution
    »ê(ß«)-½ÃÆ®¸£»ê-(ß«)µ¦½ºÆ®·Î½º ¿ë¾×(éÁäû)
  • aqueous solution
    ¼ö(â©)¿ë¾× (éÁäû)
  • Bray's solution
    ºê·¹ÀÌ ¿ë¾×(éÁäû)
  • Brodie's solution
    ºê·Îµð ¾×(äû)
  • colloidal solution
    ÄÝ·ÎÀÌµå ¿ë¾×(éÁäû)
  • concentrated solution
    ³óÃà¾×(ÒØõêäû)
  • Denhart's solution
    µ§Çϸ£Æ® ¿ë¾×(éÁäû)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anisotonic solution
    ºñµîÀå¾×
  • replenisher solution
    Áõ¾×
  • s solution
    ¸µ°Å¾×
  • solution
    ¿ë¾×, ¿ë»ó
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç°­µµ
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
US/LS upper strength/lower strength [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TMR Topical Magnetic Resonance
MEN Multiple Endocrine Neoplasia
MEN I Multiple Endocrine Neoplasia
MEN 1 Multiple Endocrine Neoplasia Type 1
MEN-I Multiple Endocrine Neoplasia Type I
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • extra chromosome
    °úÀ× ¿°»öü
    »ý¹° Á¾¿¡ À־ Á¤»óÀûÀÎ ¿°»öü ±¸¼º¿øÀÌ ¾Æ´Ñ ¿°»öü. Áï, »ý¹°Àº Á¾¸¶´Ù ÀÏÁ¤ÇÑ ¿°»öü ¼ö·Î ÇÑ Á¶¸¦ ÀÌ·é´Ù. ÀÌ ¿°»öü Á¶ÀÇ Á¤»óÀûÀÎ ±¸¼º¿ø
  • extra systole
    ±â¿Ü ¼öÃà
  • extra-articular
    °üÀý ¹Ù±ùÀÇ, °üÀý¿ÜÀÇ
  • fluoride topical application
    Ç÷ç¿À¸£ µµÆ÷¹ý
  • topical anesthesia
    ±¹¼Ò ¸¶Ãë, Ç¥¸é ¸¶Ãë, µµÆ÷ ¸¶Ãë
  • topical dental drug
    µµÆ÷¿ë Ä¡°ú ¾àÁ¦
  • topical eosin
    µµÆ÷¼º ¿¡¿À½Å
  • topical glucocorticoids poisoning
    ±¹¼Ò¼º ´çÁú ÄÚ¸£Æ¼ÄÚÀ̵å Áßµ¶
  • topical steroid
    µµÆ÷¼º ½ºÅ×·ÎÀ̵å
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
men Human adult males as cultural, psychological, sociological, political, and economic entities.
(12 Dec 1998)
paraganglioma, extra-adrenal A relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the carotid body, glomus jugulare, and aortic bodies. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. They are uncommon before the age of 20, with a female predominance in some series.
(12 Dec 1998)
extra 1. Something in addition to what is due, expected, or customary; something in addition to the regular charge or compensation, or for which an additional charge is made; as, at European hotels lights are extras.
2. <prefix> Without, outside of.
Source: Websters Dictionary
(21 Jun 2000)
extra-abdominal desmoid A deep-seated firm tumour, most frequently occurring on the shoulders, chest, or back of young men or women, consisting of collagenous fibrous tissue that infiltrates surrounding muscle; frequently recurs but does not metastasize.
(05 Mar 2000)
extra-anatomic bypass A vascular bypass that does not conform to the preexisting anatomy.
(05 Mar 2000)
extra-articular <anatomy> Situated outside of a joint.
Source: Websters Dictionary
(01 Mar 1998)
extra-axial Off the axis; applied to intracerebral lesions that do not arise from the brain itself.
(05 Mar 2000)
extra-floral Of nectaries, not within the flower.
(09 Oct 1997)
extra nodal lymphoma <oncology, tumour> Literally outside the lymph nodes, but exhibiting the characteristics of lymph node cancer. A term used to describe the extent and site of disease.
(27 Sep 1997)
extra-ocular muscle disease <radiology> Graves disease, pseudotumour, lymphoma, metastasis, infection, carotid-cavernous fistula, granulomatous disease
(12 Dec 1998)
anti-inflammatory agent, topical Anti-inflammatory agent that are applied to the skin and whose pharmacological effect only occurs at the area of application.
(12 Dec 1998)
glucocorticoids, topical A class of corticosteroids that produces suppression of inflammatory diseases when applied as ointments, lotions, or other topical dosage forms. Penetration of the preparations may be increased by means of occlusive dressings.
(12 Dec 1998)
prednisolone, topical Prednisolone that is applied topically as an anti-inflammatory agent.
(12 Dec 1998)
hydrocortisone, topical Hydrocortisone that is applied topically as an anti-inflammatory agent.
(12 Dec 1998)
topical <pharmacology> Pertaining to a particular surface area, as a topical anti-infective applied to a certain area of the skin and affecting only the area to which it is applied.
Origin: Gr. Topikos
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • topical
    È­Á¦ÀÇ;¹®Á¦°¡ µÇ¾î ÀÖ´Â;Á¦¸ñ¿¡ °üÇÑ;¿øÄ¢ÀûÀÎ;ÃÑ·ÐÀûÀÎ;½Ã»ç¹®Á¦ÀÇ;´º½º ¿µÈ­
  • men
    manÀÇ º¹¼öÇü
  • strength
    Èû,¼¼·Â,ÀåÁ¡
  • field strength
    ÀåÀÇ ¼¼±â;Àü°è °­µµ
  • green men
    ¿ìÁÖÀÎ;È­¼ºÀÎ
  • impact strength
    (Àç·áÀÇ)Ãæ°Ý °­µµ
  • men
    manÀÇ º¹¼ö
  • men's lib(liberation)
    ³²¼º ÇØ¹æ ¿îµ¿(±×·ì)(ÀüÅëÀûÀ¸·Î ³²¼º¿¡°Ô ¸¸ °úÇØÁ® ¿Â ¿ªÇÒ¿¡¼­ ºÎÅÍÀÇ ÇØ¹æ)
  • merry men
    Á¾ÀÚ;ºÎÇÏ
  • radio field intensity (strength)
    ÀüÆÄ °­µµ;ÀüÀÚÀå °­µµ
  • strength
    Èû;°­Çϱâ;°­µµ;³óµµ;º´·Â;È¿·Â;ÀúÇ×(³»±¸)·Â;ÈûÀÌ µÇ´Â °Í;ÀÇÁö;on the ~ of;...À» ÀÇÁöÇÏ¿©(¹Ð°í)
  • ab extra
    ¿ÜºÎ·Î ºÎÅÍ
  • solution
    ÇØ°á
  • Ringer's solution
    ¸µ°Å¾×
  • extra
    Ưº°ÇÑ;°¡¿ÜÀÇ;°¡¿Ü·Î;Ưº°È÷;ÀÓ½ÃÀÇ(·Î);°¡¿Ü¹°°Ç;Ưº°ÇÑ ¹°°Ç;°æÇ°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á